Neridronic acid

From Wikipedia, the free encyclopedia
  (Redirected from Neridronate)
Jump to navigation Jump to search
Neridronic acid
Neridronic acid.png
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ECHA InfoCard100.163.818 Edit this at Wikidata
Chemical and physical data
FormulaC6H17NO7P2
Molar mass277.14 g/mol g·mol−1
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

Neridronic acid (INN; the anion is called neridronate) is a bisphosphonate. In Italy it is used to treat Osteogenesis imperfecta and Paget's disease of bone.[1]

A 2013 clinical trial suggests CRPS Type I (Complex regional pain syndrome) responds to treatment with intravenous neridronate.[2]

References[edit]

  1. ^ Gatti D, Viapiana O, Idolazzi L, Fracassi E, Adami S. "Neridronic acid for the treatment of bone metabolic diseases". Expert Opin Drug Metab Toxicol. 5: 1305–11. doi:10.1517/17425250903029190. PMID 19761412.
  2. ^ Varenna M, Adami S, Rossini M, et al. (March 2013). "Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study". Rheumatology. 52 (3): 534–42. doi:10.1093/rheumatology/kes312. PMID 23204550.